A. Schols (Maastricht, The Netherlands)
Lactate dehydrogenase isozymes in skeletal muscle of COPD patients
S. H. Torres, M. Montes de Oca, E. Loeb, P. Zabner de Oziel, V. Wallis, N. Hernández, B. Anchústegui, C. Tálamo (Caracas, Venezuela)
|  |
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort
D. Caillaud, P. Carré, R. Escamilla, P. Chanez, P. R. Burgel, G. Jebrak, I. Court-Fortune, G. Brinchault-Rabin, C. Leroyer, F. Lemoigne, N. Roche, and Investigators for the ²Initiatives BPCO² Scientific Committee (Paris, France)
| |
Content of IL-6 and IL-10 in blood of COPD patients depending on presence of left and right ventricular dysfunction
V. A. Nevzorova, D. A. Barkhatova, P. A. Lukyanov (Vladivostok, Russian Federation)
| |
Prevalence of psychiatric disorders in 143 consecutive moderate to severe COPD patients in a pulmonary outpatient facility in Germany
W. Schuermann, K. Kuehl, W. Rief (Marburg, Germany)
| |
The relationship among pulmonary function tests, tumour necrosis factor-α, resting energy expenditure, and nutritional status in patients with COPD
G. Ulubay, A. Gorek, F. Oner Eyuboglu, N. Bayraktar, I. Eminsoy (Ankara, Turkey)
| |
Subjective global assessment to reveal nutritional status in patients with COPD
G. Ulubay, A. Gorek, S. Sarinc Ulasli, S. Akcay, F. Oner Eyuboglu (Ankara, Turkey)
| |
Relationships between inflammatory markers, reactive oxygen species and body mass index in stable COPD patients
Y. S. Hwang, H. S. Ham, H. C. Kim (Jinju, Republic Of Korea)
| |
Oxidative stress in patients with COPD and pulmonary hypertension
P. Joppa, D. Petrasova, B. Stancak, R. Tkacova (Kosice, Slovakia)
| |
Lipid profile in current smokers with COPD
D. Gorbatchev, A. Ramirez-Venegas, J. Regalado, J. J. Hicks, R. H. Sansores, R. Hernandez, A. Guzman, M. M. Mayar (Mexico City, Mexico)
| |
Gastroesophageal reflux in COPD patients
D. A. Todea, N. N. Ariesanu, D. Boldeanu (Cluj Napoca, Romania)
| |
Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease
M. Sanzharovskaya, N. Varvjanskaya, N. Jamkina, I. Pechorkina, A. Budkova, E. Rosljakova, G. Chernogoryuk (Tomsk, Russian Federation)
| |
Staging COPD with body mass index and fat free mass index: relations with parameters expressing disease severity
E. Ischaki, E. Gaki, G. Papatheodorou, I. Papa, V. Grammenou, S. Loukides (Athens, Greece)
| |
The frequency and types of cardiac arrhythmias in patients who suffer from COPD and chronic pulmonary heart treated in the special hospital ²Sokobanja² – Sokobanja
J. Canic, V. Canic, S. Petrovic, M. Milenkovic, I. Filipovic (Sokobanja, Serbia And Montenegro)
| |
Nutritional evaluation in COPD
A. Baccioglu, T. Acican (Kirikkale, Ankara, Turkey)
| |
Nutritional status assessment in COPD population
B. Kuznar-Kaminska, B. Brajer, H. Batura-Gabryel (Poznan, Poland)
| |
The overlap syndrome in COPD patients in outpatient clinic
M. Rzymkowska, T. Piorunek, J. Gozdzik, S. Cofta (Poznan, Poland)
| |
Calcium and magnesium blood levels of COPD patients with respiratory muscle dysfunction
T. O. Pertseva, O. V. Myronenko (Dniepropetrovsk, Ukraine)
| |
Anemia in COPD and related factors
U. Akturk, A. Fidan, G. Sarac, N. Kiral, M. Tokmak, B. Caglayan (Istanbul, Turkey)
| |
Reasons of malnutrition development in COPD
A. Baccioglu, T. Acican (Ankara, Turkey)
| |
Are biological markers correlated with nutritional status in stable COPD?
M. Kakoura, D. Chloros, A. Fleva, A. Giannakou, S. Vogiatzis, E. Fouka, K. Siomos, A. Pavlitou (Thessaloniki, Greece)
| |